Founded in 2020, Steriscience is a sterile injectables CDMO. We partner with pharmaceutical and biotech companies across the product lifecycle, from formulation development and 505(b)(2) support through technology transfer, validation and commercial manufacturing. Alongside our CDMO services, we hold select B2B partnerships on value-added injectable products.
Steriscience is committed to advancing patient care through the development and manufacturing of value-added sterile injectables that improve clinical workflows, reduce medication waste, and enhance efficiency in healthcare settings.
With a differentiated product portfolio, deep scientific expertise, and two state-of-the-art manufacturing facilities, we address critical challenges in the sterile injectables market, including supply reliability, sterility assurance, and technical complexity. By combining innovation, quality, and operational excellence, we are expanding global access to essential injectable therapies and helping healthcare providers deliver better patient outcomes.
Our facilities are a trusted hub for sterile injectables, backed by an elite tier of global regulatory approvals from FDA, EU GMP, TGA, MHRA , Health Canada and Middle East.
- Integrity
- Competency
- Efficiency
Our Values
Our objective is to achieve our desired goals by embracing a set of values that form the core of all our behaviour, actions, decisions, and processes. We live our values by demonstrating the highest levels of ethics to deliver our mission.
The three core values for Steriscience are:
30 Years of Heritage
Over 30 years of sterile manufacturing heritage a global partner of choice for critical hospital medications, combining deep market knowledge with a sophisticated manufacturing ecosystem.
Our Mission
We strive to improve patient care through innovative, value-added delivery formats that simplify complex treatments going beyond simple production to drive the future of sterile injectable care through expertise and innovation. We ensure every injectable we produce meets the highest standards of quality.
Leadership Team
Ankit Gupta
Chief Executive Officer
Tarun Singh
Chief Financial Officer
Swamy K N
Chief Technical Officer
Swati Kumari
VP , Global business development
Sangeetha K
VP & Head , Group Regulatory Affairs
Mohit Kumar
Head of Poland Site Operations
Ashwin John
Director, Planning & Projects
Edyta Lipiec
Poland Quality & Pharma Operations Head
Navigating Global Markets Through Select B2B Partnerships for Value-Added Products
Since inception, Steriscience has developed 15+ products and completed 20+ regulatory filings, securing initial approvals in key markets, including Europe.
We have established strategic partnerships with leading hospital-focused companies across anti-infectives, critical care, and value-added injectables, with multiple product launches planned in the coming year.
As we continue to expand our specialty and ready-to-use portfolio, we are actively seeking partnerships across USA, Europe, Latin America, APAC, and MENA to broaden patient access to critical hospital medicines worldwide.
Our mission is to become a trusted global injectables partner, improving patient access and advancing healthcare outcomes worldwide.
In-Licensing & Out-Licensing Opportunities
Co-Development Partnerships
Contract Manufacturing (CMO) Services
Global Presence
An emerging, differentiated B2B injectable platform with extensive global reach.
- USA
- Europe
- LATAM
- APAC (AU)
- India
- MENA